Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection

Laboratory Investigation

Volumn 93, Issue 8, 2013, Pages 900-910

  Imai, Denise M ^a   Feng, Sunlian ^a   Hodzic, Emir ^a   Barthold, Stephen W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Borrelia burgdorferi; Decorin; Decorin binding proteins; Lyme disease; Mouse model

Indexed keywords

ANTISERUM; DECORIN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL CLEARANCE; BORRELIA BURGDORFERI; CONNECTIVE TISSUE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; LYME DISEASE; MICROENVIRONMENT; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SPIROCHETE; TISSUE DISTRIBUTION; TROPISM;

ANIMALS; BORRELIA BURGDORFERI; CELLULAR MICROENVIRONMENT; COLLAGEN TYPE I; CONNECTIVE TISSUE; DECORIN; DISEASE MODELS, ANIMAL; FEMALE; HOST-PATHOGEN INTERACTIONS; IMMUNIZATION, PASSIVE; IMMUNOCOMPROMISED HOST; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, SCID; SPIROCHAETALES;

EID: 84881076840     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.81     Document Type: Article

References (55)

1. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004;113: 1093-1101.
2. Cabello FC, Godfrey HP, Newman SA. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol 2007;15: 350-354.
3. Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann NY Acad Sci 1988;539: 65-79.
4. Barthold SW, Persing DH, Armstrong AL, et al. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol 1991;139: 263-273.
5. Shih CM, Pollack RJ, Telford SR, et al. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice. J Infect Dis 1992;166: 827-831.
6. Barthold SW, Hodzic E, Tunev S, et al. Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect Immun 2006;74: 4817-4825.
7. Barthold SW, de Souza MS, Janotka JL, et al. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993;143: 959-971.
8. Schoen RT. A case revealing the natural history of untreated Lyme disease. Nat Rev Rheumatol 2011;7: 179-184.
9. Nocton JJ, Dressler F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330: 229-234.
10. Li X, McHugh GA, Damle N, et al. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or Lyme arthritis. Arthritis Rheum 2011;63: 2238-2247.
11. Armstrong AL, Barthold SW, Persing DH, et al. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg 1992;47: 249-258.
12. Cadavid D, O'Neill T, Schaefer H, et al. Localization of Borrelia burgdorferi in the nervous system and other organs in the nonhuman primate model of Lyme disease. Lab Invest 2000;80: 1043-1054.
13. Cadavid D, Bai Y, Hodzic E, et al. Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest 2004;84: 1439-1450.
14. Imai DM, Barr BC, Daft B, et al. Lyme neuroborreliosis in 2 horses. Vet Pathol 2011;48: 1151-1157.
15. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edn, New York, NY, USA, 2002.
16. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997;61: 136-169.
17. Antonara S, Ristow L, Coburn J. Adhesion mechanisms of Borrelia burgdorferi. Adv Exp Med Biol 2011;715: 35-49.
18. Guo BP, Norris SJ, Rosenberg LC, et al. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun 1995;63: 3467-3472, 33.
19. Guo BP, Brown EL, Dorward DW, et al. Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 1998;30: 711-723, 38.
20. Parveen N, Leong JM. Identification of a candidate glycosaminoglycan- binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000;35: 1220-1234.
21. Brissette CA, Bykowski T, Cooley AE, et al. Borrelia burgdorferi RevA antigen binds host fibronectin. Infect Immun 2009a;77: 2802-2812.
22. Verma A, Brissette CA, Bowman A, et al. Borrelia burgdorferi BmpA is a laminin-binding protein. Infect Immun 2009;77: 4940-4946.
23. Brissette CA, Verma A, Bowman A, et al. The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology 2009b;155: 863-872.
24. Coburn J, Chege W, Magoun L, et al. Characterization of a candidate Borrelia burgdorferi b3-chain integrin ligand identified using phage display library. Mol Microbiol 1999;34: 9266-9940.
25. Zambrano MC, Beklemisheva AA, Bryksin AV, et al. Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect Immun 2004;72: 3138-3146, 34.
26. Antonara S, Chafel RM, LaFrance M, et al. Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol 2007;66: 262-276.
27. Liang FT, Brown EL, Wang T, et al. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 2004;165: 977-985.
28. Liang FT, Jacobs MB, Bowers LC, et al. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 2002;195: 415-422.
29. Barthold SW, Feng S, Bockenstedt LK, et al. Protective and arthritisresolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 1997;25: S9-S17.
30. Casjens S, Palmer N, van Vugt R, et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000;35: 490-516.
31. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;390: 580-586.
32. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57: 521-525.
33. Hodzic E, Feng S, Freet KJ, et al. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect Immun 2003;71: 5042-5055.
34. Feng S, Hodzic E, Stevenson B, et al. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection in laboratory mice. Infect Immun 1998;66: 2827-2835.
35. Barthold SW, deSouza M, Feng S. Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 1996;74: 57-67.
36. Roberts WC, Mullikin BA, Lathigra R, et al. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect Immun 1998;66: 5275-5285.
37. Benoit VM, Fischer JR, Lin YP, et al. Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells. Infect Immun 2011;79: 3501-3509.
38. Hanson MS, Cassatt DR, Guo BP, et al. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect Immun 1998;66: 2143-2153.
39. Danielson KG, Baribault H, Holmes DF, et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136: 729-743.
40. Reissen R, Isner JM, Blessing E, et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994;144: 962-974.
41. Farquharson C, Robins SC. Immunolocalization of collagen types I and III in the arterial wall of the heart. Histochem J 1989;21: 172-178.
42. Adhikari N, Carlson M, Lerman B, et al. Changes in expression of proteoglycan core proteins and heparin sulfate enzymes in the developing and adult murine aorta. J Cardiovasc Trans Res 2011;4: 313-320.
43. Seidler DG, Dreier R. Decorin and its galactosaminoglycan chain: Extracellular regulator of cellular function? IUBMB Life 2008;60: 729-733.
44. Bianco P, Fisher LW, Young MF, et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990;38: 1549-1563.
45. Godfrey HP. Pathogenesis of chronic bacterial infections. Trends Microbiol 1998;6: 303.
46. Strother KO, Hodzic E, Barthold SW, et al. Infection of mice with Lyme disease spirochetes constituitively produducing outer surface proteins A and B. Infect Immun 2007;75: 2786-2794.
47. Cassatt DR, Patel NK, Ulbrandt ND, et al. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect Immun 1998;66: 5379-5387.
48. Tunev SS, Hastey CJ, Hodzic E, et al. Lymphadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B cell activation. PLoS Pathog 2011;7: e1002066.
49. Shi Y, Xu Q, McShan K, et al. Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun 2008a;76: 1239-1246.
50. Shi Y, Xu Q, Seemanaplli SV, et al. Common and unique contributions of decorin-binding proteins A and B to the overall virulence of Borrelia burgdorferi. Plos One 2008b;3: e3340.
51. Imai DM, Samuels DS, Feng S, et al. The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis. Infect Immun 2013;81: 1663-1673.
52. Weening EH, Parveen N, Trzeciakowski JP, et al. Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun 2008;76: 5694-5705.
53. Xu Q, Seemanaplli SV, McShan K, et al. Increasing the interaction of Borrelia burgdorferi with decorin significantly reduces the 50 percent infectious dose and severely impairs dissemination. Infect Immun 2007;75: 4272-4281.
54. LaRocca TJ, Benach JL. The important and diverse roles of antibodies in the host response to Borrelia infections. Curr Top Microbiol Immunol 2008;319: 63-103.
55. Young D, Hussell T, Dougan G. Chronic bacterial infections: living with unwanted guests. Nat Immunol 2002;3: 1026-1032.